- Aurora Cannabis (TSX:ACB) issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships
- The company became aware of an article posted on a news website falsely claiming that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics
- A second article incorrectly reported that Aurora had signed a partnership with MediPharm (TSX:LABS) distribute medical cannabis in Germany and other European Union markets
- Aurora Cannabis stock (TSX:ACB) last traded at C$6.40
Top Canadian global medical cannabis company Aurora Cannabis (TSX:ACB) has issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships.
The company became aware of an article posted on a news website falsely claiming that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Aurora categorically stated that it…
